Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 21: What are the normal serum uric acid levels in males?

A. 3.1 - 7 mg/dl (Correct Answer)
B. 2.5 - 5.6 mg/dl
C. 1.2 - 3.3 mg/dl
D. 1.8 - 4.4 mg/dl

Explanation: **Explanation:** Uric acid is the final breakdown product of **purine metabolism** (adenine and guanine) in humans, catalyzed by the enzyme **xanthine oxidase**. Because humans lack the enzyme *uricase*, which converts uric acid into the more soluble allantoin, uric acid levels must be tightly regulated through renal excretion (two-thirds) and intestinal elimination (one-third). 1. **Why Option A is correct:** In adult males, the normal reference range for serum uric acid is typically **3.1 to 7.0 mg/dL**. The upper limit is higher in males than in females because estrogens increase the renal clearance of uric acid. Hyperuricemia is generally defined as levels **>7.0 mg/dL** in men, which exceeds the solubility limit of monosodium urate in plasma at physiological pH. 2. **Why Options B, C, and D are incorrect:** * **Option B (2.5 - 5.6 mg/dL):** This range is more characteristic of **adult females**. * **Options C and D:** These values are significantly below the physiological norm for healthy adults and may be seen in pathological states like Fanconi syndrome or severe liver disease, or in pediatric populations. **NEET-PG High-Yield Pearls:** * **Gout:** Occurs when serum levels exceed the saturation point (~6.8–7.0 mg/dL), leading to the deposition of **monosodium urate crystals** (needle-shaped, negatively birefringent) in joints. * **Tumor Lysis Syndrome:** A critical cause of secondary hyperuricemia due to rapid nucleic acid breakdown following chemotherapy. * **Lesch-Nyhan Syndrome:** An X-linked recessive deficiency of **HGPRT**, leading to excessive uric acid production, self-mutilation, and mental retardation. * **Drug Interaction:** Low-dose aspirin inhibits uric acid excretion, while high-dose aspirin is uricosuric.

Question 22: Which of the following is known as the "flipping effect"?

A. LDH 1 > LDH 2 (Correct Answer)
B. LDH 2 > LDH 1
C. LDH 2 > LDH 3
D. LDH 3 > LDH 2

Explanation: ### Explanation **The Concept of the "Flipping Effect"** Lactate Dehydrogenase (LDH) is a tetrameric enzyme with five isoenzymes (LDH 1–5). In a healthy individual, **LDH 2** is the most abundant isoenzyme in the serum, followed by LDH 1. Therefore, the normal ratio is **LDH 2 > LDH 1**. In the event of a **Myocardial Infarction (MI)**, the heart muscle (which is rich in LDH 1) releases large amounts of this isoenzyme into the bloodstream. Within 24 to 48 hours of the infarct, the concentration of LDH 1 rises so significantly that it exceeds LDH 2. This reversal of the normal serum pattern (where **LDH 1 > LDH 2**) is clinically referred to as the **"Flipping Effect"** or a "flipped LDH" profile. **Analysis of Options:** * **Option A (Correct):** LDH 1 > LDH 2 represents the flipped pattern diagnostic of myocardial damage or hemolytic anemia. * **Option B:** LDH 2 > LDH 1 is the **normal physiological state** in healthy serum. * **Options C & D:** These ratios do not characterize the "flipping effect." LDH 3 is typically elevated in pulmonary conditions (like pulmonary embolism), but it is not part of the classic flipped ratio used for MI diagnosis. **Clinical Pearls for NEET-PG:** * **Diagnostic Timing:** LDH levels begin to rise 10–12 hours after an MI, peak at 48–72 hours, and remain elevated for 7–10 days. This makes it a useful marker for **late diagnosis of MI**. * **Other Causes:** A flipped LDH pattern is also seen in **Hemolytic Anemia** and **Megaloblastic Anemia** (due to high LDH 1 in RBCs). * **Current Practice:** While "flipped LDH" is a classic exam topic, it has been largely replaced in modern clinical practice by **Cardiac Troponins (I and T)**, which are more specific and sensitive.

Question 23: Which substance is NOT typically found in the urine of a patient with obstructive jaundice?

A. Urobilinogen (Correct Answer)
B. Direct bilirubin
C. Both urobilinogen and direct bilirubin
D. Neither urobilinogen nor direct bilirubin

Explanation: **Explanation:** In **obstructive (post-hepatic) jaundice**, the flow of bile from the liver to the intestine is physically blocked (e.g., by gallstones or pancreatic cancer). This disruption in the enterohepatic circulation is the key to understanding the urinary findings. **1. Why Urobilinogen is the correct answer:** Urobilinogen is formed in the intestine by the action of bacterial enzymes on conjugated bilirubin. In obstructive jaundice, conjugated bilirubin cannot reach the intestine due to the blockage. Consequently, no urobilinogen is produced. Since there is no urobilinogen in the gut to be reabsorbed into the blood, it is **absent** from the urine. **2. Why the other options are incorrect:** * **Direct (Conjugated) Bilirubin:** In obstruction, conjugated bilirubin "regurgitates" from the hepatocytes into the bloodstream. Because conjugated bilirubin is water-soluble, it is readily filtered by the kidneys, leading to **bilirubinuria** (dark "tea-colored" urine). Thus, it *is* found in the urine. * **Options C and D:** These are incorrect because they fail to distinguish between the presence of bilirubin and the absence of urobilinogen. **High-Yield Clinical Pearls for NEET-PG:** * **Acholuric Jaundice:** Refers to hemolytic jaundice where unconjugated bilirubin (water-insoluble) is elevated; it cannot pass into urine, so the urine contains no bilirubin. * **Clay-colored stools:** Occur in obstructive jaundice because stercobilin (the pigment derived from urobilinogen) is absent in the feces. * **Van den Bergh Reaction:** Obstructive jaundice gives a **Direct Positive** result (due to conjugated bilirubin). * **Summary Rule:** * *Obstructive Jaundice:* Urine Bilirubin (+), Urine Urobilinogen (-). * *Hemolytic Jaundice:* Urine Bilirubin (-), Urine Urobilinogen (↑↑).

Question 24: Which of the following statements is FALSE regarding the levels of cardiac biomarkers following ischemic injury to the heart?

A. Troponin peaks earlier than CK-MB.
B. Troponin returns to normal in three days. (Correct Answer)
C. CK-MB is less sensitive than troponin.
D. CK-MB returns to normal in 48-72 hours.

Explanation: In clinical biochemistry, understanding the kinetics of cardiac biomarkers is crucial for diagnosing and managing Myocardial Infarction (MI). **Explanation of the Correct Answer (Option B):** The statement "Troponin returns to normal in three days" is **FALSE**. Cardiac Troponins (cTnI and cTnT) are highly sensitive and specific markers of myocardial injury. While they begin to rise 3–6 hours after an ischemic event, they remain elevated for a prolonged period. **Troponin I (cTnI)** stays elevated for **5–10 days**, and **Troponin T (cTnT)** can remain elevated for up to **10–14 days**. This extended window makes Troponins excellent for late diagnosis but less useful for detecting early re-infarction. **Analysis of Other Options:** * **Option A:** Troponin (specifically high-sensitivity assays) can often be detected slightly earlier or at similar intervals to CK-MB, but more importantly, it reaches its peak concentration faster in the context of reperfusion. * **Option C:** Troponin is the "Gold Standard" because it is more cardio-specific and sensitive than CK-MB, which can also be found in skeletal muscle. * **Option D:** CK-MB rises within 4–8 hours, peaks at 24 hours, and **returns to baseline within 48–72 hours**. This rapid clearance makes CK-MB the marker of choice for diagnosing **re-infarction**. **High-Yield NEET-PG Pearls:** * **Earliest Marker:** Myoglobin (rises in 1–3 hours), but it lacks specificity. * **Most Specific Marker:** Cardiac Troponin. * **Marker for Re-infarction:** CK-MB (due to its short half-life). * **False Positive CK-MB:** Can occur in hypothyroidism, chronic muscle diseases, or renal failure. * **Prognostic Value:** The degree of Troponin elevation correlates directly with the risk of mortality.

Question 25: Which amongst the following endothelin is involved in myocardial infarction?

A. Endothelin 1 (Correct Answer)
B. Endothelin 2
C. Endothelin 3
D. Endothelin 4

Explanation: **Explanation:** **Endothelin-1 (ET-1)** is the correct answer because it is the most potent endogenous vasoconstrictor and the primary isoform produced by the vascular endothelium. In the context of **Myocardial Infarction (MI)**, ET-1 levels rise significantly in response to hypoxia and ischemia. It contributes to the pathophysiology of MI by causing intense coronary vasoconstriction, promoting inflammation, and stimulating the proliferation of vascular smooth muscle cells. Elevated plasma levels of ET-1 are often used as a prognostic marker for the severity of heart failure and the extent of myocardial damage following an infarct. **Analysis of Incorrect Options:** * **Endothelin-2 (ET-2):** While structurally similar to ET-1, it is primarily produced in the kidneys and intestine. It plays a role in ovulation and renal homeostasis but is not the dominant isoform involved in cardiac ischemic events. * **Endothelin-3 (ET-3):** This isoform is mainly found in the brain and gastrointestinal tract. It is crucial for the development of neural crest-derived cells (melanocytes and enteric neurons); mutations in ET-3 are associated with Waardenburg syndrome and Hirschsprung disease. * **Endothelin-4:** This is a distractor; there is no human endothelin isoform officially designated as ET-4 (though ET-4 is sometimes used to refer to a specific peptide in other species, it is not clinically relevant in human biochemistry). **High-Yield Clinical Pearls for NEET-PG:** * **Receptors:** ET-1 acts via two G-protein coupled receptors: **$ET_A$** (vasoconstriction) and **$ET_B$** (vasodilation via NO release). * **Clinical Application:** **Bosentan** is a dual endothelin receptor antagonist used in the treatment of Pulmonary Arterial Hypertension (PAH). * **Stimuli for Release:** ET-1 release is stimulated by Angiotensin II, ADH, thrombin, and shearing forces, while it is inhibited by Nitric Oxide (NO) and Prostacyclin.

Question 26: A plasma urea to creatinine ratio of 20:1 may be seen in which of the following conditions?

A. Rhabdomyolysis
B. Ureteric calculi
C. Pre-renal failure (Correct Answer)
D. Chronic Glomerulonephritis

Explanation: ### Explanation The normal plasma urea to creatinine ratio is typically between **10:1 and 15:1**. A ratio exceeding **20:1** is a classic biochemical marker for **Pre-renal Azotemia (Pre-renal failure)**. **Why Pre-renal failure is correct:** In pre-renal states (e.g., dehydration, congestive heart failure, or hemorrhage), renal perfusion decreases. This triggers the activation of the Renin-Angiotensin-Aldosterone System (RAAS), which increases the reabsorption of sodium and water in the proximal tubules. Since **urea** follows the passive reabsorption of water, its clearance decreases significantly, leading to an elevated plasma urea level. Conversely, **creatinine** is not reabsorbed and its secretion remains relatively stable initially. This disproportionate rise in urea relative to creatinine results in a ratio >20:1. **Analysis of Incorrect Options:** * **Rhabdomyolysis:** This condition involves massive muscle breakdown, releasing large amounts of **creatinine** (from creatine) into the blood. This typically results in a **low** urea-to-creatinine ratio. * **Ureteric calculi (Post-renal):** In early obstructive uropathy, both urea and creatinine are elevated proportionally (ratio remains 10:1 to 20:1). If the obstruction persists, tubular damage may actually decrease urea reabsorption, lowering the ratio. * **Chronic Glomerulonephritis (Intrinsic Renal):** In intrinsic renal disease, the damaged tubules cannot reabsorb urea effectively. Both urea and creatinine rise equally due to decreased GFR, maintaining a **normal ratio (10:1)**. **High-Yield Clinical Pearls for NEET-PG:** * **BUN to Creatinine Ratio:** If the question uses Blood Urea Nitrogen (BUN) instead of Urea, the threshold for pre-renal azotemia is also >20:1. (Note: Urea = BUN × 2.14). * **Fractional Excretion of Sodium (FeNa):** In pre-renal failure, FeNa is typically **<1%**, whereas in intrinsic renal failure (ATN), it is **>2%**. * **Other causes of high ratio:** High protein diet, GI bleed (blood protein breakdown), and treatment with glucocorticoids (catabolic state).

Question 27: Calculate the Low-Density Lipoprotein (LDL) level given the following values: Total cholesterol = 300 mg/dL, High-Density Lipoprotein (HDL) = 25 mg/dL, and Triglycerides = 150 mg/dL.

A. 55 mg/dL
B. 95 mg/dL
C. 125 mg/dL
D. 245 mg/dL (Correct Answer)

Explanation: To calculate the LDL cholesterol level, we use the **Friedewald Equation**, which is a high-yield formula in clinical biochemistry for NEET-PG. ### **1. Explanation of the Correct Answer** The Friedewald Equation is: **LDL = Total Cholesterol – [HDL + (Triglycerides / 5)]** *Note: (Triglycerides / 5) represents Very Low-Density Lipoprotein (VLDL) cholesterol.* **Calculation:** * Total Cholesterol = 300 mg/dL * HDL = 25 mg/dL * VLDL = TG / 5 = 150 / 5 = 30 mg/dL * LDL = 300 – (25 + 30) * LDL = 300 – 55 = **245 mg/dL** Therefore, **Option D** is the correct answer. ### **2. Analysis of Incorrect Options** * **Option A (55 mg/dL):** This value represents the sum of HDL and VLDL (25 + 30). It is a step in the calculation, not the final LDL value. * **Option B (95 mg/dL):** This occurs if one incorrectly subtracts the TG value directly from the total cholesterol without dividing by 5, then subtracting HDL (300 - 150 - 25 = 125... wait, this is a common calculation error result). * **Option C (125 mg/dL):** This value is obtained if the student incorrectly uses the formula (Total Cholesterol – TG) or makes a subtraction error. ### **3. Clinical Pearls for NEET-PG** * **Limitation:** The Friedewald Equation is **invalid** if Triglycerides are **>400 mg/dL** or if the patient has Type III Hyperlipoproteinemia (Dysbetalipoproteinemia). * **Fasting State:** A fasting sample (9–12 hours) is mandatory for accurate TG measurement to avoid chylomicron interference. * **Non-HDL Cholesterol:** Calculated as (Total Cholesterol – HDL). It is increasingly used as a better predictor of cardiovascular risk than LDL alone.

Question 28: Which of the following is true of Gilbert's syndrome?

A. Increased liver transaminases
B. Unconjugated hyperbilirubinemia (Correct Answer)
C. Bleeding tendency
D. Presence of auto-antibodies

Explanation: **Explanation:** **Gilbert’s Syndrome** is the most common hereditary cause of hyperbilirubinemia, affecting approximately 3–7% of the population. It is an autosomal recessive condition characterized by a **reduction in the activity of the enzyme UDP-glucuronosyltransferase (UGT1A1)** to about 30% of normal. 1. **Why Option B is correct:** Because UGT1A1 is responsible for conjugating bilirubin with glucuronic acid in the liver, its deficiency leads to impaired conjugation. This results in isolated **unconjugated (indirect) hyperbilirubinemia**, typically triggered by stress, fasting, infection, or strenuous exercise. 2. **Why other options are incorrect:** * **Option A:** Liver transaminases (ALT/AST) remain **normal** because there is no hepatocellular damage or inflammation. * **Option C:** Bleeding tendency is seen in severe chronic liver disease (due to decreased synthesis of clotting factors) or obstructive jaundice (due to Vitamin K malabsorption). Gilbert’s is a benign condition with normal synthetic function. * **Option D:** Auto-antibodies are markers for Autoimmune Hepatitis or Primary Biliary Cholangitis, not genetic enzyme deficiencies like Gilbert’s. **High-Yield NEET-PG Pearls:** * **Genetics:** Most commonly due to a **TATAA box mutation** in the promoter region of the *UGT1A1* gene. * **Clinical Presentation:** Usually asymptomatic; jaundice is mild (bilirubin <3 mg/dL) and fluctuates. * **Diagnosis:** Isolated rise in indirect bilirubin with normal LFTs, normal CBC (to rule out hemolysis), and no bilirubin in urine (acholuric jaundice). * **Management:** No treatment is required; it is a benign "state" rather than a disease.

Question 29: An 18-year-old is brought to the emergency room following an automobile accident. Serum enzyme studies demonstrate a thousand-fold elevation of creatine kinase (CK). Which of the following tissues is most likely to be the source of the enzyme?

A. Bone
B. Brain
C. Heart
D. Skeletal muscle (Correct Answer)

Explanation: **Explanation:** The correct answer is **Skeletal muscle**. **1. Why Skeletal Muscle is Correct:** Creatine Kinase (CK) is an enzyme primarily found in tissues with high energy demands. In the context of an automobile accident, the most likely cause of a massive (thousand-fold) elevation in serum CK is **Rhabdomyolysis**—the rapid breakdown of skeletal muscle due to mechanical trauma or crush injury. Skeletal muscle contains the highest total concentration of CK in the body (specifically the **CK-MM** isoenzyme). While other tissues contain CK, only the massive bulk of skeletal muscle can release enough enzyme to reach such extreme levels (e.g., >100,000 U/L). **2. Why Other Options are Incorrect:** * **Bone:** Bone tissue does not contain significant amounts of Creatine Kinase. Elevations in bone-related pathologies usually involve Alkaline Phosphatase (ALP). * **Brain:** The brain contains the **CK-BB** isoenzyme. However, the blood-brain barrier typically prevents significant amounts of CK-BB from entering the systemic circulation, and the total mass of the brain is insufficient to cause a thousand-fold serum elevation. * **Heart:** The myocardium contains **CK-MB**. While Myocardial Infarction (MI) causes an increase in CK, the elevation is typically 10–20 times the normal limit. A thousand-fold increase is clinically inconsistent with a cardiac event and points toward systemic muscle trauma. **3. High-Yield NEET-PG Pearls:** * **Isoenzymes:** CK-MM (Skeletal Muscle), CK-MB (Cardiac), CK-BB (Brain). * **CK-MB Index:** If CK-MB is >5% of total CK, suspect MI; if <3%, suspect skeletal muscle injury. * **Clinical Complication:** In rhabdomyolysis, massive CK elevation is often accompanied by **myoglobinuria**, which can lead to Acute Tubular Necrosis (ATN) and renal failure. * **Marker of Choice:** While CK-MB was traditionally used for MI, **Cardiac Troponins (I and T)** are now the gold standard due to higher specificity.

Question 30: Which among the following is indicative of bone resorption?

A. Osteocalcin
B. Urine hydroxyproline (Correct Answer)
C. Bone specific alkaline phosphatase
D. Type 1 procollagen

Explanation: **Explanation:** Bone remodeling is a dynamic process involving a balance between **bone formation** (osteoblastic activity) and **bone resorption** (osteoclastic activity). Markers of bone metabolism are categorized based on which process they reflect. **Why Urine Hydroxyproline is Correct:** Hydroxyproline is an amino acid found predominantly in collagen. During bone resorption, osteoclasts break down the bone matrix (which is 90% Type 1 collagen), releasing hydroxyproline into the bloodstream, which is then excreted in the urine. Therefore, elevated levels of **Urine Hydroxyproline** serve as a classic biochemical marker of increased bone turnover and resorption. **Analysis of Incorrect Options:** * **A. Osteocalcin:** This is a non-collagenous protein synthesized by osteoblasts. It is a specific marker of **bone formation**. * **C. Bone-specific Alkaline Phosphatase (BAP):** This isoenzyme is located on the surface of osteoblasts. It reflects osteoblastic activity and is a primary marker for **bone formation**. * **D. Type 1 Procollagen (PINP/PICP):** These are pro-peptides cleaved from procollagen during the synthesis of Type 1 collagen. Their presence in serum indicates active **bone formation**. **High-Yield Clinical Pearls for NEET-PG:** * **Most Specific Resorption Markers:** While hydroxyproline is a traditional marker, **Urine Deoxypyridinoline (D-Pyr)** and **Serum C-telopeptide (CTX)** or **N-telopeptide (NTX)** are considered more specific as they are not influenced by dietary intake. * **Most Sensitive Formation Marker:** **Serum PINP** (Procollagen type 1 N-terminal propeptide) is currently regarded as the most sensitive marker for monitoring bone formation and response to osteoporosis therapy. * **Alkaline Phosphatase (ALP):** Total ALP can be raised in liver disease, but BAP is specific to bone. BAP is notably elevated in **Paget’s disease**.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free